MedX Health Signs MOU to Launch DermSecure™ in Brazil
Summary
MISSISSAUGA, Ontario--( BUSINESS WIRE )--MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it has signed a Memorandum of Understanding with CBD Vida LTDA, who plans to launch an ease-of-access skin scanning/assessment program throughout Brazil, using MedX’s DermSecure TM. “MedX’s DermSecure TM telemedicine platform and advanced SIAscopy imaging technology is a perfect solution for early detection," further noted Mr. Candello. MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin cancer with its DermSecure™ telemedicine platform, utilizing its SIAscopy technology. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. CBD Vida LTDA’s business relationships in Brazil are extensive and cover pharmaceuticals, medical clinics, and pharmacies, legal, regulatory, governmental, and private industry.